Wednesday, 30 April 2014

Actemra Efficacy Persists at 1 Year

LIVERPOOL (MedPage Today) -- The comparable efficacy of subcutaneous tocilizumab (Actemra) and the intravenous formulation in patients with rheumatoid arthritis persisted for a year, with safety also being similar, a researcher reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment